Availability
0
Your Basket is Empty
BG166664
BIO-X

GSK 626616 NEW

Potent inhibitor of dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) with IC50 value of 0.7 nM. Elevates hemoglobin and platelet levels in anemic mice.

Technical Data

CAS No: 1025821-33-3
Product Code: BG166664
MDL No: MFCD31689261
Chemical Formula: C18H10Cl2N4OS
Molecular Weight: 401.27

References


  • Erickson-Miller CL et al (2007). GSK626616: A DYRK3 Inhibitor as a Potential New Therapy for the Treatment of Anemia. Blood 110(11): 510.
  • Wippich F et al (2013). Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 152(4):791-805.
  • Rai AK et al (2018). Kinase-controlled phase transition of membraneless organelles in mitosis. Nature 559(7713):211-216.

Solubility

Stability

Further Information


Datasheets

Specification: View
MSDS: View

CAS No:
1025821-33-3
MDL No:
MFCD31689261
Chemical Formula:
Molecular Weight:
401.27
Product Structure
References:
1. Erickson-Miller CL et al (2007). GSK626616: A DYRK3 Inhibitor as a Potential New Therapy for the Treatment of Anemia. Blood 110(11): 510.
2. Wippich F et al (2013). Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 152(4):791-805.
3. Rai AK et al (2018). Kinase-controlled phase transition of membraneless organelles in mitosis. Nature 559(7713):211-216.
Click for Specification
Click for MSDS

For requirements greater than the catalogue prepacks email: enquiries@carbosynth.com

Custom Synthesis

For custom synthesis or special requests email: enquiries@carbosynth.com, call +44 (0)1635 578444 or fill out our contact form

Please Wait...